Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12156)
All Articles published online
|
Feb 7, 2010 (publication date) through Apr 3, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Darvish-Damavandi M, Nikfar S, Abdollahi M. A systematic review of efficacy and tolerability of mebeverine in irritable bowel syndrome. World J Gastroenterol 2010; 16(5): 547-553 [PMID: 20128021 DOI: 10.3748/wjg.v16.i5.547] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i5/547.htm |
| Number | Citing Articles |
| 1 |
Asieh Hosseini, Shekoufeh Nikfar, Mohammad Abdollahi. Probiotics use to treat irritable bowel syndrome. Expert Opinion on Biological Therapy 2012; 12(10): 1323 doi: 10.1517/14712598.2012.707179
|
| 2 |
Aileen F. Har, Joseph M. B. Croffie. Pediatric Neurogastroenterology. 2013; : 441 doi: 10.1007/978-1-60761-709-9_41
|
| 3 |
Imke Masuy, Jasper Pannemans, Jan Tack. Irritable bowel syndrome: diagnosis and management. Minerva Gastroenterologica e Dietologica 2020; 66(2) doi: 10.23736/S1121-421X.19.02640-0
|
| 4 |
Sarah Khan, Lin Chang. Diagnosis and management of IBS. Nature Reviews Gastroenterology & Hepatology 2010; 7(10): 565 doi: 10.1038/nrgastro.2010.137
|
| 5 |
Peter Henningsen, Stephan Zipfel, Heribert Sattel, Francis Creed. Management of Functional Somatic Syndromes and Bodily Distress. Psychotherapy and Psychosomatics 2018; 87(1): 12 doi: 10.1159/000484413
|
| 6 |
M. Schmulson, L. Chang. Review article: the treatment of functional abdominal bloating and distension. Alimentary Pharmacology & Therapeutics 2011; 33(10): 1071 doi: 10.1111/j.1365-2036.2011.04637.x
|
| 7 |
K. J. Lee, N. Y. Kim, J. K. Kwon, K. C. Huh, O. Y. Lee, J. S. Lee, S. C. Choi, C. I. Sohn, S. J. Myung, H. J. Park, M. K. Choi, Y. T. Bak, P. L. Rhee. Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine. Neurogastroenterology & Motility 2011; 23(12): 1098 doi: 10.1111/j.1365-2982.2011.01771.x
|
| 8 |
Paolo Quitadamo, Sara Isoldi, Saverio Mallardo, Letizia Zenzeri, Giovanni Di Nardo. Scientific Evidence for the Treatment of Children with Irritable Bowel Syndrome. Current Pediatric Reviews 2021; 17(2): 92 doi: 10.2174/1573396317666210127123330
|
| 9 |
Judith J. Korterink, Juliette M.T.M. Rutten, Leonie Venmans, Marc A. Benninga, Merit M. Tabbers. Pharmacologic Treatment in Pediatric Functional Abdominal Pain Disorders: A Systematic Review. The Journal of Pediatrics 2015; 166(2): 424 doi: 10.1016/j.jpeds.2014.09.067
|
| 10 |
Taraneh Mousavi, Mohammadhossein Sharifnia, Shekoufeh Nikfar, Mohammad Abdollahi. Pharmacotherapy for gastric and intestinal cramping pain: current and emerging therapies. Expert Opinion on Pharmacotherapy 2023; 24(18): 2021 doi: 10.1080/14656566.2023.2265830
|
| 11 |
Richard J. Saad. Peripherally Acting Therapies for the Treatment of Irritable Bowel Syndrome. Gastroenterology Clinics of North America 2011; 40(1): 163 doi: 10.1016/j.gtc.2010.12.008
|
| 12 |
V. N. Drozdov, K. I. Arefev, S. Yu. Serebrova, I. A. Komissarenko, E. V. Shikh, A. K. Starodubtsev. Role of antispasmodics in the treatment of irritable bowel syndrome. Meditsinskiy sovet = Medical Council 2021; (5): 155 doi: 10.21518/2079-701X-2021-5-155-164
|
| 13 |
Giovanni Marasco, Cesare Cremon, Maria Raffaella Barbaro, Vincenzo Stanghellini, Giovanni Barbara. Management of Irritable Bowel Syndrome With Diarrhea. Journal of Clinical Gastroenterology 2024; doi: 10.1097/MCG.0000000000001964
|
| 14 |
A Young Seo, Nayoung Kim, Dong Hyun Oh. Abdominal Bloating: Pathophysiology and Treatment. Journal of Neurogastroenterology and Motility 2013; 19(4): 433 doi: 10.5056/jnm.2013.19.4.433
|
| 15 |
Zahra Pourmoghaddas, Hossein Saneian, Hamidreza Roohafza, Ali Gholamrezaei. Mebeverine for Pediatric Functional Abdominal Pain: A Randomized, Placebo-Controlled Trial. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/191026
|
| 16 |
Shilan Mozaffari, Shekoufeh Nikfar, Mohammad Abdollahi. Metabolic and toxicological considerations for the latest drugs used to treat irritable bowel syndrome. Expert Opinion on Drug Metabolism & Toxicology 2013; 9(4): 403 doi: 10.1517/17425255.2013.759558
|
| 17 |
Aleksandra I. Goncharenko, Fedor V. Gorbovskoi, Ekaterina A. Kargina, Nadezhda M. Kondrat'eva. Therapy for irritable bowel syndrome: focus on butylbromide hyoscine. A review. Terapevticheskii arkhiv 2025; 97(2): 176 doi: 10.26442/00403660.2025.02.203191
|
| 18 |
Miguel Saps, Adrian Miranda. Gastrointestinal Pharmacology. Handbook of Experimental Pharmacology 2017; 239: 147 doi: 10.1007/164_2016_119
|
| 19 |
Ramesh R. Rai, Sandeep Nijhawan. Comparative evaluation of efficacy and safety of drotaverine versus mebeverine in irritable bowel syndrome. Saudi Journal of Gastroenterology 2021; 27(3): 136 doi: 10.4103/sjg.SJG_266_20
|
| 20 |
Amin Sharifan. In vitro Bioequivalence Study of Five Generic Products and the Innovator Brand of Mebeverine Hydrochloride Extended- Release Capsules in Iran Market. Analytical Chemistry Letters 2021; 11(3): 354 doi: 10.1080/22297928.2021.1918021
|
| 21 |
Ophir Gilad, Guy Rosner, Eli Brazowski, Revital Kariv, Nathan Gluck, Hana Strul. Management of pouch related symptoms in patients who underwent ileal pouch anal anastomosis surgery for adenomatous polyposis. World Journal of Clinical Cases 2021; 9(32): 9847-9856 doi: 10.12998/wjcc.v9.i32.9847
|
| 22 |
Judith Korterink, Niranga Manjuri Devanarayana, Shaman Rajindrajith, Arine Vlieger, Marc A. Benninga. Childhood functional abdominal pain: mechanisms and management. Nature Reviews Gastroenterology & Hepatology 2015; 12(3): 159 doi: 10.1038/nrgastro.2015.21
|
| 23 |
Ahmed Salih Sahib. Treatment of irritable bowel syndrome using a selected herbal combination of iraqi folk medicines. Journal of Ethnopharmacology 2013; 148(3): 1008 doi: 10.1016/j.jep.2013.05.034
|
| 24 |
S. Nikfar, R. Rahimi, M. Abdollahi. A Systematic Review on the Efficacy of Interferon Beta in Relapsing Remitting Multiple Sclerosis; Comparison of Different Formulations. International Journal of Pharmacology 2010; 6(5): 638 doi: 10.3923/ijp.2010.638.644
|
| 25 |
Kyung Ho Song, Hye-Kyung Jung, Hyun Jin Kim, Hoon Sup Koo, Yong Hwan Kwon, Hyun Duk Shin, Hyun Chul Lim, Jeong Eun Shin, Sung Eun Kim, Dae Hyeon Cho, Jeong Hwan Kim, Hyun Jung Kim. Clinical Practice Guidelines for Irritable Bowel Syndrome in Korea, 2017 Revised Edition. Journal of Neurogastroenterology and Motility 2018; 24(2): 197 doi: 10.5056/jnm17145
|
| 26 |
Aileen F. Har, Joseph M. B. Croffie. Pediatric Neurogastroenterology. 2017; : 469 doi: 10.1007/978-3-319-43268-7_44
|
| 27 |
Ankita Wal, Pranay Wal, Neha Verma, Shiv Shanker Pandey, Karthickeyan Krishnan, Mithun Bhowmick. Children and Adolescents with Irritable Bowel Syndrome: Treatment and
Management. Current Pediatric Reviews 2024; 20(2): 166 doi: 10.2174/1573396319666221128094843
|
| 28 |
Full-Young Chang. Is Otilonium Bromide Really Effective for Treating Asian Patients With Irritable Bowel Syndrome?: Author's Reply. Journal of Neurogastroenterology and Motility 2012; 18(1): 111 doi: 10.5056/jnm.2012.18.1.111
|
| 29 |
|
| 30 |
Surya Prakash Mishra, Sunit Kumar Shukla, Bajrang Lal Pandey. A preliminary evaluation of comparative effectiveness of riluzole in therapeutic regimen for irritable bowel syndrome. Asian Pacific Journal of Tropical Biomedicine 2014; 4: S335 doi: 10.12980/APJTB.4.2014C205
|
| 31 |
Igor V. Maev, Olga Z. Okhlobystina, Igor L. Khalif, Dmitry N. Andreev. Irritable bowel syndrome in the Russian Federation: results of the ROMERUS multicenter observational study. Terapevticheskii arkhiv 2023; 95(1): 38 doi: 10.26442/00403660.2023.01.202043
|
| 32 |
Chun-Yan Li, Shu-Chuen Li. Treatment of irritable bowel syndrome in China: A review. World Journal of Gastroenterology 2015; 21(8): 2315-2322 doi: 10.3748/wjg.v21.i8.2315
|
| 33 |
Jaroslaw Daniluk, Ewa Malecka-Wojciesko, Barbara Skrzydlo-Radomanska, Grazyna Rydzewska. The Efficacy of Mebeverine in the Treatment of Irritable Bowel Syndrome—A Systematic Review. Journal of Clinical Medicine 2022; 11(4): 1044 doi: 10.3390/jcm11041044
|
| 34 |
Azar Asadi-Shahmirzadi, Shilan Mozaffari, Yara Sanei, Maryam Baeeri, Reza Hajiaghaee, Hamid Reza Monsef-Esfahani, Mohammad Abdollahi. Benefit of Aloe vera and Matricaria recutita mixture in rat irritable bowel syndrome: Combination of antioxidant and spasmolytic effects. Chinese Journal of Integrative Medicine 2012; doi: 10.1007/s11655-012-1027-9
|
| 35 |
DwaipayanSarathi Chakraborty, Avijit Hazra, Amrita Sil, Shantasil Pain. Will controlled release mebeverine be able to surpass placebo in treatment of diarrhoea predominant irritable bowel syndrome?. Journal of Family Medicine and Primary Care 2019; 8(10): 3173 doi: 10.4103/jfmpc.jfmpc_522_19
|
| 36 |
Miglena Milusheva, Mihaela Stoyanova, Vera Gledacheva, Iliyana Stefanova, Mina Todorova, Mina Pencheva, Kirila Stojnova, Slava Tsoneva, Paraskev Nedialkov, Stoyanka Nikolova. 2-Amino-N-Phenethylbenzamides for Irritable Bowel Syndrome Treatment. Molecules 2024; 29(14): 3375 doi: 10.3390/molecules29143375
|
| 37 |
Edoardo Savarino, Fabiana Zingone, Brigida Barberio, Giovanni Marasco, Filiz Akyuz, Hale Akpinar, Oana Barboi, Giorgia Bodini, Serhat Bor, Giuseppe Chiarioni, Gheorghe Cristian, Maura Corsetti, Antonio Di Sabatino, Anca Mirela Dimitriu, Vasile Drug, Dan L. Dumitrascu, Alexander C. Ford, Goran Hauser, Radislav Nakov, Nisha Patel, Daniel Pohl, Cătălin Sfarti, Jordi Serra, Magnus Simrén, Alina Suciu, Jan Tack, Murat Toruner, Julian Walters, Cesare Cremon, Giovanni Barbara. Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility. United European Gastroenterology Journal 2022; 10(6): 556 doi: 10.1002/ueg2.12259
|
| 38 |
Dmitry I. Trukhan, Viktoriia V. Goloshubina. Irritable bowel syndrome: current aspects of etiology, pathogenesis, clinic and treatment: A review. Consilium Medicum 2022; 24(5): 297 doi: 10.26442/20751753.2022.5.201861
|
| 39 |
Bong Ki Cha, Chang Hwan Choi, Sae Kyung Chang. Efficacy of Ramosetron in Male Patients With Irritable Bowel Syndrome With Diarrhea (Neurogastroenterol Motil 2011;23:1098-1104). Journal of Neurogastroenterology and Motility 2012; 18(2): 224 doi: 10.5056/jnm.2012.18.2.224
|
| 40 |
Yang Won Min, Poong-Lyul Rhee. The clinical potential of ramosetron in the treatment of irritable bowel syndrome with diarrhea (IBS-D). Therapeutic Advances in Gastroenterology 2015; 8(3): 136 doi: 10.1177/1756283X15572580
|
| 41 |
Susan Lucak, Lin Chang, Albena Halpert, Lucinda A. Harris. Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice. Therapeutic Advances in Gastroenterology 2017; 10(2): 253 doi: 10.1177/1756283X16663396
|
| 42 |
Taraneh Mousavi, Shekoufeh Nikfar, Mohammad Abdollahi. An update on efficacy and safety considerations for the latest drugs used to treat irritable bowel syndrome. Expert Opinion on Drug Metabolism & Toxicology 2020; 16(7): 583 doi: 10.1080/17425255.2020.1767067
|
| 43 |
Mustafa Abdul Karim, Nadeen Al-Baz, Peter M. Haddad, Shuja M. Reagu, Majid Alabdulla. Buspirone in the management of refractory irritable bowel syndrome. Medicine 2021; 100(51): e28003 doi: 10.1097/MD.0000000000028003
|
| 44 |
Robyn Rexwinkel, Nicolaas Koen Vermeijden, Judith Zeevenhooven, Johannes Kelder, Michael Groeneweg, Thalia Hummel, Joery Goede, Pamela Hurkmans, Janneke Stapelbroek, Marc Benninga, Arine Vlieger. Mebeverine and the Influence of Labeling in Adolescents With Irritable Bowel Syndrome or Functional Abdominal Pain Not Otherwise Specified: A 2 × 2 Randomized, Placebo-Controlled Trial. Gastroenterology 2025; doi: 10.1053/j.gastro.2025.02.030
|
| 45 |
Robyn Rexwinkel, Judith Zeevenhooven, Faridi S. van Etten-Jamaludin, Marc A. Benninga, Merit M. Tabbers. Side effects associated with pharmacotherapy for pediatric irritable bowel syndrome and functional abdominal pain – not otherwise specified: a systematic review. Expert Opinion on Drug Safety 2019; 18(2): 111 doi: 10.1080/14740338.2019.1574295
|
| 46 |
Full-Young Chang, Ching-Liang Lu, Jiing-Chyuan Luo, Tseng-Shing Chen, Mei-Jung Chen, Hsiu-Ju Chang. The Evaluation of Otilonium Bromide Treatment in Asian Patients With Irritable Bowel Syndrome. Journal of Neurogastroenterology and Motility 2011; 17(4): 402 doi: 10.5056/jnm.2011.17.4.402
|
| 47 |
William D. Chey, Monthira Maneerattaporn, Richard Saad. Pharmacologic and Complementary and Alternative Medicine Therapies for Irritable Bowel Syndrome. Gut and Liver 2011; 5(3): 253 doi: 10.5009/gnl.2011.5.3.253
|
| 48 |
Miglena Milusheva, Vera Gledacheva, Iliyana Stefanova, Mina Pencheva, Rositsa Mihaylova, Yulian Tumbarski, Paraskev Nedialkov, Emiliya Cherneva, Mina Todorova, Stoyanka Nikolova. In Silico, In Vitro, and Ex Vivo Biological Activity of Some Novel Mebeverine Precursors. Biomedicines 2023; 11(2): 605 doi: 10.3390/biomedicines11020605
|
| 49 |
Adrian Miranda, Miguel Saps. The Use of Non-Narcotic Pain Medication in Pediatric Gastroenterology. Pediatric Drugs 2014; 16(4): 293 doi: 10.1007/s40272-014-0080-6
|
| 50 |
P. Layer, V. Stanghellini. Review article: linaclotide for the management of irritable bowel syndrome with constipation. Alimentary Pharmacology & Therapeutics 2014; 39(4): 371 doi: 10.1111/apt.12604
|
| 51 |
Paul Enck, Florian Junne, Sibylle Klosterhalfen, Stephan Zipfel, Ute Martens. Therapy options in irritable bowel syndrome. European Journal of Gastroenterology & Hepatology 2010; : 1 doi: 10.1097/MEG.0b013e3283405a17
|
| 52 |
M. A. Osadchuk, M. M. Osadchuk. Antispasmodics in the treatment of abdominal syndrome in IBS and IBS-like syndrome in modern clinical practice. Medical alphabet 2025; (34): 7 doi: 10.33667/2078-5631-2024-34-7-12
|